Correlation Between Molecular Partners and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and AN2 Therapeutics, you can compare the effects of market volatilities on Molecular Partners and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and AN2 Therapeutics.
Diversification Opportunities for Molecular Partners and AN2 Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and AN2 is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Molecular Partners i.e., Molecular Partners and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Partners and AN2 Therapeutics
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 2.12 times more return on investment than AN2 Therapeutics. However, Molecular Partners is 2.12 times more volatile than AN2 Therapeutics. It trades about 0.11 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.43 per unit of risk. If you would invest 487.00 in Molecular Partners AG on November 2, 2024 and sell it today you would earn a total of 36.00 from holding Molecular Partners AG or generate 7.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. AN2 Therapeutics
Performance |
| Timeline |
| Molecular Partners |
| AN2 Therapeutics |
Molecular Partners and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and AN2 Therapeutics
The main advantage of trading using opposite Molecular Partners and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Molecular Partners vs. Surrozen | Molecular Partners vs. Armata Pharmaceuticals | Molecular Partners vs. Pasithea Therapeutics Corp | Molecular Partners vs. Aditxt Inc |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |